Physician

Uday Dandamudi, MD

According to 2025 Medicare claims, Uday Dandamudi, MD (NPI: 1992759096) practices hematology/oncology in the Tampa, FL market, with the plurality of this provider's patient population coming from Pasco, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 34655-1808.

Dandamudi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 618 traditional Medicare patients, billed 170,500 HCPCS/CPT codes, and received $2,822,764 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,510 prescription claims across 375 beneficiaries totaling $3,344,620 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 57 claims. Open Payments data shows 196 records totaling $13,213. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,188,143 to $2,822,764. Similarly, Part D prescription costs have risen steadily, from $542,794 to $3,344,620. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,216 to $189.